Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Director/PDMR Shareholding

5 Apr 2022 16:17

RNS Number : 3718H
Elementis PLC
05 April 2022
 

 

5 April 2022

 

 

Elementis plc('Elementis' or 'the Company') 

 

Director/PDMR Shareholding

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

 

Elementis plc announces that on 4 April 2022 the following Directors have been granted conditional share awards under the Elementis plc 2018 Long Term Incentive Plan (LTIP) with a vesting date of 4 April 2025 at a cost of nil pence per share.

 

Name

Title

Number of shares

(Performance Share Awards)

Paul Waterman

Chief Executive Officer

1,236,244

Ralph Hewins

Chief Financial Officer

559,656

 

The above quantum of awards are as detailed in the 2021 Directors' Remuneration Report and are based on award multiples set at 200% and 175% of salary for both the Chief Executive and Chief Financial Officer respectively.

 

In addition, the Committee will retain discretion to reduce the number of shares on vesting should it be considered appropriate to do so (e.g. in the event that there was perceived windfall gain).

 

Subject to the terms of the LTIP plan rules, the above awards will vest and become exercisable from the third anniversary of the grant of the awards subject to continued service and to the extent to which the relevant performance conditions (see below) are satisfied over the three financial years ending 31 December 2024. Shares that vest (post selling any shares required to meet associated tax liabilities) are also subject to a two-year holding requirement.

 

Performance conditions

The full performance conditions to apply to the 2022 awards are as follows:

Earnings per share (33% weighting)

 

EPS

% of EPS part vesting

Less than 13 cents

0%

13 cents

0%

17.5 cents

100%

Vesting will be on a straight-line basis between performance points.

 

Relative Total Shareholder Return (33% weighting)

 

Elementis versus FTSE ALL Share Constituents (excluding Investment Trusts)

% of TSR part vesting

Below median

0%

Median

25%

Upper quartile

100%

Vesting will be on a straight-line basis between the median and upper quartile.

 

Operating Cash Conversion (33% weighting)

 

Three-year Operating Cash Conversion

% of Operating Cash Conversion part vesting

Less than 85%

0%

85%

0%

95%

100%

Vesting will be on a straight-line basis between performance points.

 

Vesting based on the above performance conditions will be subject to a return on capital employed underpin. This will require the Committee to consider the vesting result determined based on the application of the EPS, TSR and operating cash conversion performance conditions in light of the return on capital employed achieved during the three year period ending 31 December 2024 relative to the Board's internal plans over the period. If the Committee does not consider the vesting result appropriate in light of the return the underpin enables vesting to be reduced to a more appropriate level.

 

Set out below are the notifications made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

PAUL WATERMAN

2

Reason for the notification

a)

Position/status

CEO, DIRECTOR

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ELEMENTIS PLC

b)

LEI

549300LQIH685LI2ML36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

SHARES

 

GB0002418548

 

b)

Nature of the transaction

Grant of a conditional share award over 1,236,244 shares under the Elementis plc 2018 Long Term Incentive Plan with a vesting date of 4 April 2025 at a cost of nil pence per share.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

N/A

N/A

 

 

d)

Aggregated information

 

 

 

 

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

2022-04-04

f)

Place of the transaction

Outside of a trading venue

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

RALPH HEWINS

2

Reason for the notification

a)

Position/status

CFO, DIRECTOR

b)

Initial notification/Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ELEMENTIS PLC

b)

LEI

549300LQIH685LI2ML36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

 

Identification code

SHARES

 

GB0002418548

 

b)

Nature of the transaction

Grant of a conditional share award over 559,656 shares under the Elementis plc 2018 Long Term Incentive Plan with a vesting date of 4 April 2025 at a cost of nil pence per share.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

N/A

N/A

 

 

d)

Aggregated information

 

 

 

 

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

2022-04-04

f)

Place of the transaction

Outside of a trading venue

 

 

 

 

 

 

 

Person responsible for making this notification: Laura Higgins, Group Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASLSEFSAEFA
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.